FDA Approvals

Date Posted
Article Title
11/20/2014
Abuse-Resistant Prescription Painkiller Approved

Hysingla ER is only for chronic pain, and is formulated to resist crushing, dissolving

10/29/2014
10/24/2014
New Treatment Approved for Rare Form of Hemophilia

The bleeding disorder affects both males and females

10/16/2014
Esbriet, Ofev Approved to Treat Deadly Lung Disease

Drugs help slow decline of idiopathic pulmonary fibrosis

10/14/2014
Urinary Prosthetic Device for Women Approved

Helps those who can't contract bladder muscles

10/13/2014
Drug-Coated Balloon Catheter Approved

Designed to clear clogged arteries in thigh and knee

10/10/2014
Akynzeo Approved for Side Effects of Chemotherapy

Drug helps ease nausea, vomiting

9/23/2014
Blood Test for Yeast Infections Approved

Rare infections primarily affect people with weakened immune systems

9/19/2014
Trulicity Approved for Type 2 Diabetes

New drug helps regulate blood sugar

9/16/2014
Movantik Approved for Constipation From Opioids

Painkillers frequently cause irregularity

9/11/2014
Novel Weight-Loss Drug Is Approved

For obese people or overweight people with weight-related health condition

9/5/2014
NephroCheck Test Approved to Predict Kidney Injury Risk

Screens for decline of kidney function within 12 hours

9/4/2014
Keytruda Approved for Advanced Melanoma

Nearly 10,000 in U.S. expected to die this year from deadly skin cancer

8/21/2014
New Test Helps Diagnose Type 1 Diabetes

But negative result doesn't rule out disease, FDA warns

8/20/2014
Cerdelga Approved for Gaucher Disease

People with rare disorder lack key enzyme

8/15/2014
Avastin Approved for Late-Stage Cervical Cancer

More than 4,000 women projected to die this year from the disease

8/14/2014
Belsomra Approved for Insomnia

First such drug designed to affect sleep-wake cycle

8/12/2014
Donor-Lung Preservation Device Approved

Technology may lead to more transplants, FDA says

8/12/2014
New Colorectal Cancer Screening Test Approved

Disease is the second-leading cause of cancer death in United States

8/7/2014
Orbactiv Approved for Drug-Resistant Skin Infections

Third such antibiotic sanctioned this year